Cancer Clinical Trial -Coordination Pharmaceuticals-CPI-300CL21-01
Cancer
Status:
OpenClinicalTrials.gov:
NCT04808453Phase I Study of CPI-300 in Patients With Advanced Tumors (CPI-300)
Phase I Study of CPI-300 in Patients With Advanced Tumors (CPI-300)